MarketPeel
Insider Trading Intelligence
Pricing
…
RB

Rene Bernards

LIXT
DIRECTOR · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · CIK 0001939159
FILING MIX · LIFETIME100%/0%
BUYS
14
SELLS
0
TOTAL VALUE
$89.8K
COMPANIES
1
ACTIVE SINCE
Nov 2022
HOLDINGS NOW
10,000
AVG SELL PX
—
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Rene Bernards, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+40.00%-3.53%-0.41%-3.12%-4.88%—
14d5+40.00%-4.05%+0.11%-4.17%-6.34%—
30d5+60.00%-0.23%+0.90%-1.13%-1.08%—
60d5+60.00%+36.34%+5.37%+30.97%+0.47%—
90d5+60.00%+22.57%+5.32%+17.24%+19.85%—
180d5+60.00%+12.29%+14.95%-2.66%+5.55%—
1y5+0.00%-45.82%+25.60%-71.42%-67.78%—
2y5+40.00%-2.27%+58.69%-60.97%-122.98%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LIXT · 10,000 shares · as of Jun 30, 2025
037,50075,000112,500150,000202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
FLOW · 14 buys / 0 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
10,662——10,662Jun 30, 2025Jul 8, 2025 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 30, 2025Jul 8, 2025 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
8,045——8,045Mar 31, 2025Apr 1, 2025 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
4,166——4,166Jan 20, 2025Jan 22, 2025 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
5,304——5,304Sep 30, 2024Oct 28, 2024 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 30, 2024Jul 5, 2024 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASEGRANT
Stock grant
4,149——4,149Jun 30, 2024Jul 5, 2024 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASE
5,527$2.51$13.9K25,000Oct 3, 2023Oct 5, 2023 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASE
5,527$2.51$13.9K—Oct 3, 2023Oct 4, 2023 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASE
4,473$2.29$10.2K19,473Oct 2, 2023Oct 5, 2023 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASE
4,473$2.29$10.2K—Oct 2, 2023Oct 4, 2023 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASE
15,000$0.51$7.7K150,000Dec 15, 2022Dec 15, 2022 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASE
10,000$0.61$6.1K135,000Dec 12, 2022Dec 13, 2022 ↗View →
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
PURCHASE
52,500$0.53$27.8K125,000Nov 14, 2022Nov 15, 2022 ↗View →
Other insiders · LIXT
Loading peer insiders…
About this filer
CIK 0001939159
ROLE
Director
PRIMARY
LIXT
COMPANIES
1
ACTIVE SINCE
Nov 2022
MARKETPEEL · /INSIDER/0001939159DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback